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ABSTRACT
Background: Liver transplantation is frequently associated with hyperkalemia, 
especially after graft reperfusion. Dual hypothermic oxygenated machine perfusion 
(DHOPE) reduces ischemia/reperfusion injury and improves graft function, compared 
to conventional static cold storage (SCS). We examined the effect of DHOPE on ex situ 
and in vivo shifts of potassium and sodium.
Methods: Potassium and sodium shifts were derived from balance measurements in a 
preclinical study of livers that underwent DHOPE (n=6) or SCS alone (n=9), followed by 
ex situ normothermic reperfusion. Similar measurements were performed in a clinical 
study of DHOPE-preserved livers (n=10) and control livers that were transplanted after 
SCS only (n=9).
Results: During DHOPE, preclinical and clinical livers released a mean of 17±2 and 
34±6 mmol potassium and took up 25±9 and 24±14 mmol sodium, respectively. After 
subsequent normothermic reperfusion, DHOPE-preserved livers took up a mean of 
19±3 mmol potassium, while controls released 8±5 mmol potassium. During liver 
transplantation, blood potassium levels decreased upon reperfusion of DHOPE-
preserved livers while levels increased after reperfusion of SCS-preserved liver, delta 
potassium levels were -0.77±0.20 vs. +0.64 ± 0.37 mmol/L, respectively (P = 0.002).
Conclusion: While hyperkalemia is generally anticipated during transplantation of 
SCS-preserved livers, reperfusion of hypothermic machine perfused livers can lead to 
decreased blood potassium or even hypokalemia in the recipient.  




Liver transplantation is frequently accompanied by acute hyperkalemia during 
reperfusion, which may lead to life-threatening arrhythmia. Several factors are known 
to contribute to hyperkalemia during liver transplantation, including the release of 
potassium rich preservation solution, cell lysis during graft reperfusion, metabolic 
acidosis, and massive transfusion of red blood cells (1-4). To counteract an anticipated 
acute rise of potassium after graft reperfusion, anesthesiologists may take preventive 
measures, such as the administration of glucose/insulin, bicarbonate, calcium or 
measures as hyperventilation (5,6). 
Recently, end-ischemic hypothermic (oxygenated) machine perfusion of donor livers has 
been introduced into clinical practice as a new method of organ preservation. Compared 
to SCS alone, additional graft preservation via hypothermic (oxygenated) machine 
perfusion reduces ischemia/reperfusion injury of liver grafts during transplantation 
(7-9). The perfusion fluid that is currently used in Europe and the US for hypothermic 
machine perfusion is Belzer’s University of Wisconsin (UW) machine perfusion solution. 
Compared to UW cold storage solution, UW machine perfusion solution contains more 
sodium (100 mmol/L vs 29 mmol/L) and less potassium (25 mmol/L vs 125 mmol/L), 
although this is still much higher than the potassium concentration in serum. In our first 
clinical series of dual hypothermic oxygenated machine perfusion (DHOPE) of donor 
livers we noted that, in contrast to SCS-preserved livers, in vivo graft reperfusion did 
not result in acute hyperkalemia and in fact was accompanied by hypokalemia in three 
out of ten recipients (9). Little is known about cation (potassium and sodium) shifts in 
the liver during ex situ machine perfusion or during reperfusion in the recipient. As ex 
situ machine perfusion involves a closed circuit, this allows a direct calculation of cation 
uptake (influx) or release (efflux) by the liver. 
The aim of the current study is to determine the effect of DHOPE on potassium and 
sodium shifts in human donor livers during machine perfusion and subsequent warm 
reperfusion in both a preclinical ex situ reperfusion model as well as in patients.
METHODS
Study design
This study consisted of two parts: a preclinical study (part A) using human liver grafts that 
were declined for transplantation and a clinical study (part B) of patients who received a 
DHOPE-preserved liver graft. In both the preclinical and clinical study, DHOPE-preserved 
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liver grafts were compared with livers that were preserved with SCS alone (controls). 
The anonymized data analysis in both sub-studies was performed in accordance with 
national guidelines and legislation. The preclinical study protocol was approved by the 
competent authority for organ donation in the Netherlands, the Dutch Transplantation 
Foundation (NTS) and by the medical ethical committee of our institution (University 
Medical Center Groningen, record METc protocol 2012.068). Ethical approval for the 
clinical study was obtained from the same medical ethical committee (record METc 
protocol 2014.100). In addition, the study protocol of the clinical study was published in 
an open access trial registry (www.trialregister.nl; trial ID NTR4493). 
Organ procurement
All livers were procured according to a standard protocol by regional organ procurement 
teams, using a rapid flush out with ice-cold UW cold storage solution (Bridge-to-Life, 
Ltd. Northbrook, IL) and subsequent SCS in the same fluid during transportation to our 
center. The potassium concentration of UW cold storage solution is 125 mmol/L, only 
slightly lower than the intracellular concentration (140 mmol/L) (10). This minimizes 
the passive release of intracellular potassium into the extracellular milieu during SCS 
(11,12). Likewise, the sodium concentration in UW cold storage solution is 29 mmol/L, 
only slightly above the intracellular concentration (10 mmol/L) (10), minimizing influx 
of sodium.
During the back table procedure, livers were prepared for either machine perfusion in 
the preclinical (Part A) and clinical study (Part B), or for direct transplantation (controls 
in clinical study). 
Dual hypothermic oxygenated machine perfusion (DHOPE)
DHOPE was performed with 3 to 4L of UW machine perfusion solution (potassium 
concentration 25 mmol/L and sodium concentration 100 mmol/L; Bridge-to-Life, Ltd. 
Northbrook, IL) using the Liver Assist device (Organ Assist, Groningen, The Netherlands) 
according to the manufacturer’s instructions. Before the start of DHOPE, livers were 
flushed during the back table procedure with 1L of UW machine perfusion solution 
to flush out UW cold storage solution. The perfusion fluid was oxygenated to obtain a 
pO2 of approximately 80 kPa. During DHOPE portal vein perfusion pressure was set at 4 
mmHg and mean arterial perfusion pressure at 25 mmHg. 
Part A. Preclinical study
The preclinical study consisted of a total of 15 human donor livers that were declined for 
transplantation and offered to our center for research after informed consent had been 
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obtained from the relatives of the donor. Livers were selected from a previous study 
based on the type of preservation fluid used during organ procurement (13). Only livers 
preserved in UW cold storage solution were included in the current study. Livers were 
divided into two groups: 6 livers underwent 2 hours of DHOPE prior to 6 hours of ex situ 
normothermic machine perfusion (NMP) to assess liver graft viability and function, and 
9 livers underwent 6 hours of NMP without prior perfusion with DHOPE. 
NMP was performed using the same Liver Assist device, using a solution based on 
packed red blood cells and plasma, as described previously (13-15). Prior to NMP, all 
livers were flushed with 1L cold NaCl 0.9% solution, followed by 500 mL warm NaCl 0.9% 
solution to flush out UW cold storage (control livers) or UW machine perfusion solution 
(DHOPE livers). Oxygenation resulted in a pO2 between 50 and 80k kPa. During NMP 
perfusion pressures were set at 11 mmHg for the portal vein and a mean of 70 mmHg 
for the hepatic artery. 
Part B. Clinical study
The clinical study included 10 patients undergoing liver transplantation, who received 
a liver that underwent 2 hours of DHOPE prior to implantation. Similar to the preclinical 
study, DHOPE was applied for 2 hours after conventional SCS. The control group 
consisted of 9 patients who underwent transplantation without DHOPE treatment of 
the liver. They were matched for recipient age (±5 years), donor warm ischemia time 
(±5 minutes), and MELD score (6-22 or ≥23). Livers were selected from a previously 
published clinical study (9). Only livers preserved in UW cold storage during the SCS 
phase were included. 
All liver grafts were implanted by using the piggy back technique without veno-venous 
bypass. Graft reperfusion was initiated by restoration of portal venous flow. To avoid 
hyperkalemia in the recipient, the first 400 mL of blood effluent from the liver was 
discarded before systemic venous return was established in both DHOPE and control 
livers. Subsequently the hepatic artery anastomosis was constructed and arterial blood 
flow to the liver was restored. 
Assessment of cation concentrations and shifts
During machine perfusion (either DHOPE or NMP), perfusate samples were collected 
at baseline (prior to connecting liver) and every 30 minutes thereafter. During 
transplantation, blood samples of the recipient were collected from a non-heparinized 
arterial line: 1) prior to the anhepatic phase (pre-anhepatic) and 2) during the anhepatic 
phase, and 3) after portal and 4) arterial reperfusion. Perfusate samples and blood 
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samples were immediately processed for determination of potassium and sodium 
concentrations, using an ABL 800 point-of-care blood-gas analyzer (Radiometer Medical 
ApS, Brønshøj, Denmark). Hypokalemia was defined as a potassium concentration 
<3.5 mmol/L and hyperkalemia as >5.0 mmol/L. All forms of potassium or sodium 
administration (e.g. potassium chloride or sodium bicarbonate solution) during machine 
perfusion or during the transplant procedure were recorded. 
The hepatic uptake (positive shift or influx) or release (negative shift or efflux) of 
potassium during ex situ machine perfusion was calculated according to the following 
formula:
Potassium shift (mmol) = ([K+]expected delta - [K
+]observed delta) ∙ Vperfusion
where the expected delta in serum potassium concentration was defined as:
Expected delta (mmol/L) = K+administered / Vperfusion
The observed rise or decrease in potassium concentration was defined as:
Observed delta (mmol/L) = [K+ ]n+1 - [K
+ ]n 
Here n and n+1 denote two consecutive time points during machine perfusion and V 
stands for volume of the perfusion fluid. For calculating sodium shifts, similar formulae 
were used in which K+ was replaced by Na+.
Correlation between changes in cation levels and post-reperfusion 
markers of hepatic viability and injury
In the preclinical study, changes in cation levels upon ‘ex situ reperfusion’ (30 minutes 
after the start of NMP) were correlated with markers of hepatic viability (cellular ATP) 
and injury  (peak perfusate levels of ALT and lactate). In the clinical study, changes of 
cation levels upon graft reperfusion were correlated with post-operative peak levels of 
serum ALT and lactate, and prothrombin time (PT) on postoperative day 1.
Correlation between changes in cation levels and post-reperfusion 
syndrome
One of the more severe hemodynamic disturbances that can occur during liver 
transplantation is post-reperfusion syndrome (PRS). PRS is defined as a drop in 
mean arterial pressure (MAP) of >30% of baseline values within 5 minutes after graft 
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reperfusion that lasts for at least 1 minute (16). In the clinical study, changes in cation 
levels were correlated with changes in  MAP and noradrenaline requirement after graft 
reperfusion.
Statistical analysis
Continuous variables are presented as median with interquartile range (IQR), or as mean 
± standard error (SE) as appropriate. Categorical variables are presented as number and 
percentage. Group characteristics were compared between groups using the Mann-
Whitney U-test for continuous variables or the Chi-square test for categorical variables. 
Strength and direction of association between two variables were determined by 
calculating the Spearman’s correlation coefficient. Changes in cation levels were 
compared with a Student t-test. A P-value <.05 was considered significant. Statistical 
analyses were performed with SPSS 23.0 (IBM, Chicago, USA).







Age (years) 64 (57-70) 62 (52-64) 0.29
Sex (male) 3 (50%) 6 (67%) 0.62



















Reason rejected for transplantation














Cold ischemia time (min)a 489 (452-513) 509 (409-660) 0.72
Time from withdrawal of life support to cold flushb (min) 33 (26-53) 43 (38-79) 0.13
Time from circulatory arrest to cold flushc (min) 15 (13-23) 20 (16-23) 0.49
Data are presented as number (percentage) or median (interquartile range). Abbreviations used; DCD, donation after 
circulatory death; DBD, donation after brain death. aCold ischemia time was defined as the interval between start aortic cold 
flush in the donor until the start of NMP or DHOPE. bThe time interval between the discontinuation of mechanical ventilation 
and the start of aortic cold flush in the donor (international donor warm ischemia time). cThe time interval between cardiac 
arrest and the start of aortic cold flush in the donor.
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RESULTS
Part A. Preclinical study
Donor characteristics 
Donor and preservation characteristics are shown in Table 1. There were no significant 
differences between the two groups in donor characteristics such as donor age, type of 
donor or donor warm ischemia time (in case of donation after circulatory death [DCD]). 
Cation concentrations and shifts during end-ischemic DHOPE  
During the first 30 minutes of DHOPE, the mean perfusate potassium level increased 
from 26.6 ± 0.8 to 33.4 ± 1.9 mmol/L (P = 0.03) and levels remained stable thereafter 
(Figure 1). The total hepatic release of potassium during 2 hours of DHOPE was 17 ± 2 
mmol.
During the first 30 minutes of DHOPE, mean perfusate sodium level remained stable (102 
± 7 to 101 ± 6 mmol/L) (P = 0.91) but during the remainder of DHOPE levels decreased 
from 102 ± 7 to 94 ± 6 mmol/L (P = 0.06) (Figure 2). The total hepatic uptake of sodium 
during 2 hours of DHOPE was 25 ± 9 mmol.
Cation concentrations, shifts and potassium-related interventions during NMP
During NMP of the DHOPE-preserved livers, potassium levels in the perfusion fluid 
decreased during the first 30 minutes from 3.5 ± 0.3 to 1.2 ± 0.1 mmol/L (P = 0.001). In 
livers that underwent NMP without prior DHOPE (controls), potassium levels increased 
during the first 30 minutes from 4.6 ± 0.4 to 9.0 ± 1.8 mmol/L (P = 0.04). Both groups 
showed stable perfusate potassium concentrations during the remainder of the NMP 
(Figure 1). 
During NMP of DHOPE-preserved livers, a total hepatic uptake of 19 ± 3 mmol of 
potassium was noted. In control (SCS alone) livers, an opposite potassium shift was 
observed with a total hepatic release of 8 ± 5 mmol. All DHOPE-preserved livers required 
potassium supplementation during NMP to maintain potassium concentrations within 
an acceptable range, while in the control livers, only two (13%) needed potassium 
supplementation (P < 0.001).
During NMP of the DHOPE-preserved livers, no changes in sodium perfusate levels were 
observed in the first 30 minutes of NMP (151 ± 1 to 149 ± 1 mmol/L, respectively; P = 
0.78) and levels remained to be stable thereafter. In livers that underwent NMP without 
prior DHOPE (controls), sodium levels decreased during the first 30 min from 147 ± 3 to 
139 ± 3 mmol/L (P = 0.02). Both groups showed stable perfusate sodium concentrations 
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during the remainder of the NMP (Figure 2). During NMP of DHOPE-preserved livers, a 
total hepatic release of 7 ± 3 mmol of sodium was noted. In control (SCS alone) livers, an 
opposite sodium shift was noted with a total hepatic uptake of 23 ± 9  mmol of sodium.
FIGURE 1. Mean potassium levels in perfusion fluid during DHOPE and NMP of preclinical 
livers. At baseline (time point zero), samples of the perfusion fluid were taken before the liver 
was connected to the perfusion device (Liver Assist). Potassium levels increased significantly 
during the first 30 minutes of DHOPE (*P = .03) and stabilized thereafter. During ex situ NMP of 
DHOPE-preserved livers, potassium levels decreased significantly during the first 30 minutes (**P 
= .001) and stabilized thereafter. In contrast, during ex situ NMP of control livers, potassium levels 
increased significantly during the first 30 minutes (***P = .04) and stabilized thereafter. Note the 
different Y-scales for DHOPE and NMP.
Correlation between changes in cation levels and postreperfusion markers of hepatic 
viability and injury
After 2 hours of NMP, cellular ATP levels were significantly higher in DHOPE-preserved 
livers compared to control livers, 88 (50-137) µmol/g vs. 36 (21-57) µmol/g respectively 
(P = 0.03). The change in potassium levels upon ex situ reperfusion correlated negatively 
with ATP levels after 2 hours of NMP (P < 0.001). In other words, an increase in potassium 
levels upon ex situ reperfusion correlated with low ATP levels (Table 3). In contrast, 
changes in sodium levels correlated positively with ATP levels after 2 hours of NMP (P 
= 0.048). Moreover, high potassium levels upon ex situ reperfusion strongly predicted 
high peak ALT levels (P < 0.001) and peak lactate levels (P < 0.001) (Table 3).
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FIGURE 2. Mean sodium levels in perfusion fluid during DHOPE and NMP of preclinical 
livers. At baseline (time point zero), samples of the perfusion fluid were taken before the liver 
was connected to the perfusion device (Liver Assist). Sodium levels remained stable during the 
first 30 minutes of DHOPE, but levels significantly decreased thereafter (*P = .06). During ex situ 
NMP of DHOPE-preserved livers, no changes in sodium perfusate levels were observed in the first 
30 minutes of NMP and levels remained to be stable thereafter. In contrast, during ex situ NMP 
of control livers, sodium levels significantly decreased during the first 30 minutes (**P = .02) and 
stabilized thereafter. Note the different Y-scales for DHOPE and NMP.
TABLE 3. Correlation between changes in cation levels and post-reperfusion markers of hepatic 
viability and injury in the preclinical study. 
Reperfusion levels
D Potassium (mmol/L) D Sodium (mmol/L)
rs P value rs P value
Cellular ATP - 0.85 < 0.001 0.58 0.048
Peak ALT  0.81 < 0.001 -0.61 0.02
Peak lactate 0.92 < 0.001 -0.72 0.008
Both DHOPE and control livers were included in a bivariate analysis to correlate changes in potassium and sodium levels 
upon ‘ex situ reperfusion’ (30 minutes after the start of NMP) with levels of cellular energy marker ATP and perfusate peak 
levels of ALT and lactate. Data are presented as Spearman’s correlation coefficient (rs). Abbreviations used; ATP: adenosine 
triphosphate, ALT: alanine aminotransferase, NMP: normothermic machine perfusion.
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Part B. Clinical study
Patient and donor characteristics 
Patient, donor and surgical characteristics are shown in Table 2. There were no significant 
differences in baseline characteristics or surgical variables between the groups. Most 
importantly, preoperative serum potassium and sodium concentrations, as well as intra-
operative blood loss and transfusion of packed red blood cells did not differ between 
the two groups.
TABLE 2. Comparison of donor and recipient characteristics of transplanted livers (Part B).
DHOPE (n=10) Control (n=9) p-value
Donor characteristics
Age (years) 53 (47-57) 55 (50-57) 0.90
Sex (male) 5 (50%) 5 (57%) 0.46




















Age (years) 57 (54-62) 57 (53-62) 0.12
Sex (male) 6 (60%) 4 (44%) 1.00
MELD score 16 (15-22) 22 (17-25) 0.12
Preservation characteristics
Cold ischemia time (min)a 311 (282-357) 430 (424-487) <0.001
Time from withdrawal of life 
support to cold flush (min)b 
27 (23-43) 36 (29-55) 0.46
Time from circulatory arrest to cold flush (min)c 15 (13–17) 17 (15-19) 0.41
Surgical variables
Estimated blood loss (mL) 3,600 (1,763-4,875) 2,700 (2,200-6,600) 0.91
Preoperative serum [K+] (mmol/L) 4.3 (4.1-4.7) 3.9 (3.9-4.7) 0.78
Preoperative serum [Na+] (mmol/L) 137 (133-141) 137 (134-141) 0.28
RBC transfusion (unit) 3 (1.5-7.5) 3 (0.5-8.5) 0.86
Data are presented as median (interquartile range) or numbers (percentages). Abbreviations used; DCD: donation after 
circulatory death, DBD: donation after brain death, MELD score: Model for End-Stage Liver Disease score, RBC: Red Blood 
Cell. aCold ischemia time was defined as the interval between start of aortic cold flush until start of DHOPE or in-vivo graft 
reperfusion. bThe time interval between the discontinuation of mechanical ventilation and the start of aortic cold flush in the 
donor (international donor warm ischemia time). cThe time interval between cardiac arrest and the start of aortic cold flush 
in the donor.
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Cation concentrations and shifts during end-ischemic DHOPE
During the first 30 minutes of DHOPE, the potassium perfusate level increased from 25.2 
± 0.6 to 33.8 ± 2.3 mmol/L (P = 0.003), and levels remained stable thereafter (Figure 3). 
The total hepatic potassium release during 2 hours of DHOPE was 34 ± 6 mmol.
During the first 30 minutes of DHOPE, sodium levels slightly decreased from 107 ± 3 
to 103 ± 2, yet this decrease did not reached significance (P = 0.22), and sodium levels 
remained stable thereafter (Figure 4). However, despite absence of a significant drop in 
sodium levels, the total (calculated) hepatic sodium uptake during 2 hours of DHOPE 
was still 24 ± 14 mmol. 
FIGURE 3. Mean potassium levels in perfusion fluid during DHOPE and in recipient blood 
samples during subsequent orthotopic liver transplantation (OLT). At baseline (time point 
zero), samples of the perfusion fluid were taken before the liver was connected to the perfusion 
device (Liver Assist). Potassium levels in the perfusion fluid increased significantly during the 
first 30 minutes of DHOPE (*P < .001), and stabilized thereafter. During OLT of DHOPE-preserved 
livers, blood potassium levels decreased significantly after reperfusion (**P = .003). Moreover, at 
the time of graft reperfusion, blood potassium levels were significantly lower in DHOPE patients 
when compared to potassium levels at that time point in control patients (***P = .03). Note the 
different Y-scales for DHOPE and NMP.
16251-burlage-layout.indd   72 05/04/2019   15:38
73
4
Cation concentrations during in vivo reperfusion and potassium-related interventions
After in vivo graft reperfusion, blood potassium levels decreased from 4.7 ± 0.2 to 3.9 ± 
0.3 mmol/L (P = 0.003) in recipients of a DHOPE-preserved liver. In recipients of a control 
(SCS alone) liver, blood potassium levels increased from 4.4 ± 0.1 to 5.0 ± 0.4 mmol/L (P 
= 0.15; Figure 3). During OLT, three (30%) recipients of a DHOPE-preserved liver required 
potassium supplementation, while no such supplementation was given to recipients of 
a control liver (P = 0.12). 
After in vivo graft reperfusion, blood sodium levels slightly increased in recipients of 
a DHOPE-treated liver (135 ± 1 to 137 ± 1 mmol/L, P = 0.04), whereas levels slightly 
decreased in control (SCS alone) recipients from 138 ± 2 to 137 ± 2 mmol/L, yet this did 
this did not reached significance (P = 0.23; Figure 4).
FIGURE 4. Mean sodium levels in perfusion fluid during DHOPE and in recipient blood 
samples during subsequent orthotopic liver transplantation (OLT). At baseline (time point 
zero), samples of the perfusion fluid were taken before the liver was connected to the perfusion 
device (Liver Assist). Sodium levels in the perfusion fluid slightly decreased, during the first 30 
minutes of DHOPE as well as during the remainder of DHOPE, yet not significantly. During OLT 
of DHOPE-preserved livers, blood sodium levels increased significantly after reperfusion (*P = 
.04). During OLT of control livers, blood sodium levels slightly decreased after reperfusion, yet not 
significantly. Note the different Y-scales for DHOPE and NMP.
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Correlation between changes in cation levels and post-reperfusion markers of hepatic 
viability and injury 
Increased potassium levels (mmol/L) upon portal reperfusion significantly correlated 
with higher peak serum ALT levels after transplantation (P = 0.001). There was no 
significant correlation between post-reperfusion serum potassium levels and lactate 
levels and post-operative prothrombin times (Table 4).
TABLE 4. Correlation between changes in cation levels and post-reperfusion syndrome. 
Reperfusion levels
D Potassium (mmol/L) D Sodium (mmol/L)
rs P value rs P value
Peak ALT 0.74 0.001 -0.38 0.11
Peak lactate 0.29 0.27 -0.27 0.26
PT (POD 1) 0.34 0.18 -0.24 0.33
D MAP -0.23 0.40 0.25 0.33
D Noradrenaline dose 0.62 0.01 -0.62 0.008
Both DHOPE and control livers were included in a bivariate analysis to correlate changes potassium and sodium levels upon 
graft reperfusion with peak levels of ALT and lactate ), and the PT value on postoperative day 1. Changes in cation levels 
were also correlated with changes in mean arterial pressure (D MAP) and changes in noradrenaline dose (D noradrenaline 
dose) upon reperfusion. Data are presented as Spearman’s correlation coefficient (rs). Abbreviations used; ALT: alanine 
aminotransferase, MAP: mean arterial pressure, PT: prothrombin time.
Correlation between changes in cation levels and post-reperfusion syndrome
In vivo reperfusion of DHOPE-preseved livers or control livers, resulted in minimal 
changes in median MAP (Figure 5). Post-reperfusion syndrome occurred in 0 out of 10 
patients in the DHOPE group and in 1 out of 7 in the control group (P = 0.44). Changes in 
MAP upon reperfusion did not correlated with changes in potassium and sodium levels 
(Table 4). Unfortunately, recordings of the MAP and noradrenaline dose around the time 
of reperfusion were missing in 2 (out of 9) patients in the control group.
During in vivo reperfusion of DHOPE-preserved livers, median noradrenaline 
requirement increased from 0.16 (0.14-0.29) mg/kg/min to 0.24 (0.23-0.48) mg/kg/min 
(P = 0.02). In controls, median noradrenaline requirement increased from 0.14 (0.14-
0.29) (mg/kg/min) to 0.27 (0.23-0.38) (mg/kg/min)  upon reperfusion, although did this 
not reach significance (P = 0.08) (Figure 5). Interestingly, increased potassium levels 
and decreased sodium levels upon reperfusion significantly correlated with increased 
noradrenaline requirement (Table 4).
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FIGURE 5. Changes in intraoperative hemodynamics upon reperfusion. No significant 
changes in mean arterial pressure (MAP) were noted after reperfusion of both DHOPE and control 
livers (Panel A) while noradrenaline requirements increased in both groups (Panel B). Increased 
noradrenaline dose upon reperfusion significantly correlated with increased potassium levels 
(Panel C) and decreased sodium levels (Panel D); P = .01 and P = 0.008, respectively. 
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FIGURE 6. Overview of potassium and sodium shifts during organ preservation and 
subsequent warm reperfusion. This cartoon summarizes cation shifts during hypothermic 
machine perfusion in both preclinical and clinical livers, and during subsequent warm 
reperfusion in the preclinical study. During static cold storage (SCS), donor livers were preserved 
in a high potassium and low sodium preservation solution, containing 125 mmol/L potassium 
and 29 mmol/L sodium. During warm reperfusion of SCS-preserved livers, a mean total hepatic 
potassium release of 8 mmol and a mean total hepatic sodium uptake of 23 mmol was observed. 
During hypothermic oxygenated machine perfusion, a mean total hepatic potassium release of 
17 mmol in the preclinical and 34 mmol in the clinical study was noted. Simultaneously, a total 
hepatic sodium uptake of 25 mmol was noted during hypothermic machine perfusion in the 
preclinical study and of 24 mmol in the clinical study. Opposite cation shifts were observed during 
subsequent warm reperfusion of liver grafts. During reperfusion of DHOPE-preserved livers, a 
total hepatic potassium uptake of 19 mmol and a total hepatic sodium release of 7 mmol was 
noted, whereas reperfusion of a SCS-preserved livers was associated with a total hepatic release 
of 8 mmol potassium and a total hepatic uptake of 23 mmol of sodium. These differences in cation 
shifts explains the risk of a post-reperfusion systemic hyperkalemia in recipients of a conventional 
SCS-preserved liver and a decrease in blood potassium levels in recipients of a DHOPE-preserved 
liver. Abbreviations used; UW: University of Wisconsin, SCS solution: static cold storage solution, 
MP solution: machine perfusion solution.




In contrast to transplantation of conventional, SCS-preserved livers, which is accompanied 
by a risk of acute hyperkalemia, transplantation of livers that underwent hypothermic 
oxygenated machine perfusion was associated with a decrease in recipient blood 
potassium levels after graft reperfusion. These findings have clinical consequences for 
the perioperative management of liver transplant recipients as anesthesiologists and 
surgeons should anticipate a possible need for potassium administration to maintain 
normokalemia upon graft reperfusion of a liver graft that underwent hypothermic 
oxygenated machine perfusion.
To our knowledge, this is the first study in which potassium and sodium shifts after 
reperfusion of DHOPE-preserved livers were examined. We observed hepatic potassium 
release during DHOPE and hepatic potassium uptake after warm reperfusion of DHOPE-
preserved livers. Hepatic uptake of potassium upon warm reperfusion occurred both 
ex situ during NMP and in vivo during transplantation. In contrast, control livers that 
underwent only conventional SCS showed potassium release during warm reperfusion. 
Hepatic cation shifts during DHOPE and subsequent warm reperfusion or during SCS 
and warm reperfusion are summarized in Figure 6.
Physiologically, the liver serves as a buffer for enteral potassium loads. Cellular potassium 
uptake requires active transport by the ATP-dependent Na+/K+-ATPase (4,17). Low 
temperatures (8-12 degrees Celsius) during DHOPE are likely to impair optimal function 
of Na+/K+-ATPase, thereby facilitating passive potassium release (18). The total mean 
hepatic release of potassium during DHOPE varied from 17 mmol in preclinical livers 
to 34 mmol clinical livers (Figure 5). Also, as a consequence of impaired Na+/K+-ATPase 
during DHOPE, the total mean hepatic sodium uptake was 25 to 29 mmol in preclinical 
and clinical livers, respectively. Moreover, in line with previously published data, cellular 
ATP levels were significantly higher in DHOPE preserved livers compared to controls 
upon ex situ reperfusion (13). Furthermore, this study showed that high ATP levels upon 
reperfusion significantly correlated with decreased potassium. This underlines the 
potential role of the ATP dependent hepatic potassium uptake in DHOPE-preserved 
livers. Moreover, in both our preclinical and clinical study, increased potassium levels 
correlated with high peak ALT levels upon reperfusion. In other words, a decrease in 
potassium levels upon reperfusion might therefore be an interesting ‘early prediction’ 
marker of good liver function. However, futures studies are necessary to confirm this. 
A decrease in blood potassium levels, as observed after reperfusion of DHOPE-
preserved liver grafts, is a remarkable and otherwise rarely observed phenomenon 
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in patients undergoing liver transplantation. One previous study reported a slight 
decrease in potassium levels after reperfusion of UW-preserved liver grafts compared to 
histidine-tryptophan-ketoglutarate solution in adult living donor liver transplantations 
(19). It must be noted that, due to logistical differences between post-mortal and 
living donor liver transplantations, cold ischemia times (mean 66 minutes) in this study 
were substantially shorter than cold ischemia times in our study groups. In pediatric 
liver transplantation, hypokalemia after graft reperfusion is more commonly seen. The 
underlying mechanism has yet to be elucidated (20). Both living donor and pediatric 
liver transplant procedures can, however, not be compared with our patient group. 
The first clinical series of oxygenated hypothermic machine perfusion did not report 
potassium or sodium concentrations (21). However, Guarrera, et al. published the first 
clinical series of transplantation of non-oxygenated hypothermic machine perfused 
(HMP) liver grafts (7). These authors used a perfusion solution with the same potassium 
content as Belzer-UW machine perfusion solution (25 mmol/L). Changes in potassium 
levels during the first 30 minutes of HMP were not reported, but potassium levels were 
stable at approximately 30 mmol/L during the remainder of HMP. This level of potassium 
is comparable to the potassium levels in the perfusion fluid during DHOPE in our 
preclinical and clinical studies. Altogether, this suggests that similar shifts in potassium 
have occurred in the liver machine perfusions described by Guarrera, et al, although the 
authors have not specifically noted this in their publication (7).
While DHOPE and NMP constitute closed systems that are well suited to measure cation 
shifts, this was not possible during reperfusion in vivo. Nevertheless, the preclinical and 
clinical studies collectively point into the same direction and provide an explanation for 
the observed decrease in blood potassium levels in recipients of a DHOPE-preserved 
liver.
As hypothermic oxygenated machine perfusion, e.g. DHOPE and HOPE, are entering the 
clinical arena as a method to reduce ischemia-reperfusion injury in liver transplantation, 
it is of utmost importance that transplant anesthesiologists anticipate a decrease rather 
than an increase in blood potassium concentration after graft reperfusion. Current pre-
emptive anti-hyperkalemic measures, such as the use of glucose/insulin and sodium 
bicarbonate, might aggravate the decrease in blood potassium concentrations after 
reperfusion of DHOPE-preserved livers. In our study, potassium supplementation was 
required more frequently during transplantation of a DHOPE-preserved liver, compared 
to transplantation of a conventional SCS preserved liver. Modified perioperative 
management is thus appropriate during transplantation of a liver that underwent 
hypothermic oxygenated machine perfusion. 
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Another clinical challenge that anesthesiologists may encounter during graft 
reperfusion is hemodynamic instability. While the exact pathophysiology of this post-
reperfusion syndrome (PRS) is not clearly understood, it has been correlated with high 
potassium levels and increased ischemia-reperfusion injury (22). In this study we did 
not observe PRS in the DHOPE group. In the control group, 1 out of 7 (14%) patients 
demonstrated PRS, which is in the lower range of the reported incidence of PRS during 
OLT (varying between 12% and 77%) (23). In our study, median MAPs remained stable 
in both groups with adequate increases of the noradrenaline dose. We did, however, 
observe that increase noradrenaline requirements upon reperfusion correlated with 
increased potassium levels and decreased sodium levels. It has to be noted that data on 
MAP and inotropic doses were not complete in 2 out of 9 control patients.
The decrease instead of increase in blood potassium concentration after reperfusion 
of a DHOPE-preserved liver graft may actually be helpful in patients with concomitant 
renal insufficiency. Many patients with end-stage liver disease also have some degree of 
renal failure, making them more prone for difficult to control hyperkalemia. The increase 
in blood potassium concentrations after reperfusion of a SCS-preserved liver graft may 
cause cardiovascular instability due to arrhythmias in these patients and this problem 
should be less frequent after reperfusion of a DHOPE-preserved liver. 
In conclusion, while hyperkalemia is generally anticipated during transplantation of a 
SCS-preserved liver, reperfusion of a DHOPE-preserved liver is associated with potassium 
uptake by the liver, which can lead to a decrease in blood potassium concentrations or 
even hypokalemia. Anesthesiologists and surgical teams should be prepared for this 
opposite shift in potassium during transplantation.
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